Table Of Content

1.Executive Summary

2.Market Introduction
2.1.Market Definition
2.2.Market Taxonomy

3.Widefield Imaging Market Analysis Scenario
3.1.Market Volume Analysis
3.1.1.Installed Base By Region
3.1.2.Replacement Rate and Lifecycle Analysis
3.2.Pricing Analysis
3.2.1.Pricing Assumptions
3.2.2.Price Projections Per Region
3.3.Market Overview
3.3.1.Value Chain

4.Widefield Imaging Market Dynamics
4.1.Macro-economic Factors
4.2.Drivers
4.2.1.Supply Side
4.2.2.Demand Side
4.3.Restraints
4.4.Opportunity
4.5.Forecast Factors - Relevance and Impact
4.6.Price Trend Analysis

5.Global Widefield Imaging Market Analysis and Forecast, By Component
5.1.Introduction
5.1.1.Basis Point Share (BPS) Analysis By Usability
5.1.2.Y-o-Y Growth Projections By Usability
5.2.Market Size (US$ Mn) Forecast By Component
5.2.1.Instrument
5.2.2.Software
5.2.2.1.Image Viewing Software
5.2.2.2.Data Analysis and Interpretation Software
5.3.Market Attractiveness Analysis, By Product

6.Global Widefield Imaging Market Analysis and Forecast, By Indication
6.1.Introduction
6.1.1.Basis Point Share (BPS) Analysis By Indication
6.1.2.Y-o-Y Growth Projections By Indication
6.2.Market Size (US$ Mn) Forecast By Indication
6.2.1.Diabetic Retinopathy
6.2.2.Retinopathy of Prematurity
6.2.3.Pediatric Retinal Diseases
6.2.4.Retinal Vein Occlusion
6.2.5.Ocular Oncology
6.2.6.Uveitis
6.2.7.Chorioretinal Diseases
6.2.8.Glaucoma
6.2.9.Others (age-related macular degeneration; central serous chorioretinopathy (CSR))
6.3.Market Attractiveness Analysis By Indication

7.Global Widefield Imaging Market Analysis and Forecast, By Modality
7.1.Introduction
7.1.1.Basis Point Share (BPS) Analysis By End User
7.1.2.Y-o-Y Growth Projections By End User
7.1.3.Comparative Analysis By End User
7.2.Market Size (US$ Mn) Forecast By End User
7.2.1.Standalone
7.2.2.Portable
7.3.Market Attractiveness Analysis By End User

8.Global Widefield Imaging Market Analysis and Forecast, By End User
8.1.Introduction
8.1.1.Basis Point Share (BPS) Analysis By End User
8.1.2.Y-o-Y Growth Projections By End User
8.1.3.Comparative Analysis By End User
8.2.Market Size (US$ Mn) Forecast By End User
8.2.1.Specialty Clinics
8.2.2.Hospitals
8.2.3.Ambulatory Surgical Centers
8.3.Market Attractiveness Analysis By End User

9.Global Widefield Imaging Market Analysis and Forecast, By Region
9.1.Introduction
9.1.1.Basis Point Share (BPS) Analysis By Region
9.1.2.Y-o-Y Growth Projections By Region
9.2.Market Size (US$ Mn) Forecast By Region
9.2.1.North America
9.2.2.Western Europe
9.2.3.Asia Pacific Excl. Japan (APEJ)
9.2.4.Japan
9.2.5.Latin America
9.2.6.Eastern Europe
9.2.7.Middle East and Africa (MEA)
9.3.Market Attractiveness Analysis By Region

10. North America Widefield Imaging Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis By Country
10.1.2. Y-o-Y Growth Projections By Country
10.1.3. Key Regulations
10.2. Market Size (US$ Mn) Forecast By Country
10.2.1. U.S.
10.2.2. Canada
10.3. Market Size (US$ Mn) Forecast By Component
10.3.1. Instrument
10.3.2. Software
10.3.2.1. Image Viewing Software
10.3.2.2. Data Analysis and Interpretation Software
10.4. Market Size (US$ Mn) Forecast By Indication
10.4.1. Diabetic Retinopathy
10.4.2. Retinopathy of Prematurity
10.4.3. Pediatric Retinal Diseases
10.4.4. Retinal Vein Occlusion
10.4.5. Ocular Oncology
10.4.6. Uveitis
10.4.7. Chorioretinal Diseases
10.4.8. Glaucoma
10.4.9. Others (age-related macular degeneration; central serous chorioretinopathy (CSR))
10.5. Market Size (US$ Mn) Forecast By End User
10.5.1. Specialty Clinics
10.5.2. Hospitals
10.5.3. Ambulatory Surgical Centers
10.6. Market Size (US$ Mn) Forecast By Modality
10.6.1. Standalone
10.6.2. Portable
10.7. Market Attractiveness Analysis
10.7.1. By Country
10.7.2. By Component
10.7.3. By Indication
10.7.4. By End User
10.7.5. By Modality
10.8. Prominent Trends
10.9. Drivers and Restraints: Impact Analysis

11. Latin America Widefield Imaging Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis By Country
11.1.2. Y-o-Y Growth Projections By Country
11.1.3. Key Regulations
11.2. Market Size (US$ Mn) Forecast By Country
11.2.1. Brazil
11.2.2. Mexico
11.2.3. Rest of Latin America
11.3. Market Size (US$ Mn) Forecast By Component
11.3.1. Instrument
11.3.2. Software
11.3.2.1. Image Viewing Software
11.3.2.2. Data Analysis and Interpretation Software
11.4. Market Size (US$ Mn) Forecast By Indication
11.4.1. Diabetic Retinopathy
11.4.2. Retinopathy of Prematurity
11.4.3. Pediatric Retinal Diseases
11.4.4. Retinal Vein Occlusion
11.4.5. Ocular Oncology
11.4.6. Uveitis
11.4.7. Chorioretinal Diseases
11.4.8. Glaucoma
11.4.9. Others (age-related macular degeneration; central serous chorioretinopathy (CSR))
11.5. Market Size (US$ Mn) Forecast By End User
11.5.1. Specialty Clinics
11.5.2. Hospitals
11.5.3. Ambulatory Surgical Centers
11.6. Market Size (US$ Mn) Forecast By Modality
11.6.1. Standalone
11.6.2. Portable
11.7. Market Attractiveness Analysis
11.7.1. By Country
11.7.2. By Component
11.7.3. By Indication
11.7.4. By End User
11.7.5. By Modality
11.8. Prominent Trends
11.9. Drivers and Restraints: Impact Analysis

12. Western Europe Widefield Imaging Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis By Country / Region
12.1.2. Y-o-Y Growth Projections By Country
12.1.3. Key Regulations
12.2. Market Size (US$ Mn) Forecast By Country / Region
12.2.1. Germany
12.2.2. France
12.2.3. Italy
12.2.4. Spain
12.2.5. U.K.
12.2.6. NORDIC
12.2.7. Rest of Western Europe
12.3. Market Size (US$ Mn) Forecast By Component
12.3.1. Instrument
12.3.2. Software
12.3.2.1. Image Viewing Software
12.3.2.2. Data Analysis and Interpretation Software
12.4. Market Size (US$ Mn) Forecast By Indication
12.4.1. Diabetic Retinopathy
12.4.2. Retinopathy of Prematurity
12.4.3. Pediatric Retinal Diseases
12.4.4. Retinal Vein Occlusion
12.4.5. Ocular Oncology
12.4.6. Uveitis
12.4.7. Chorioretinal Diseases
12.4.8. Glaucoma
12.4.9. Others (age-related macular degeneration; central serous chorioretinopathy (CSR))
12.5. Market Size (US$ Mn) Forecast By End User
12.5.1. Specialty Clinics
12.5.2. Hospitals
12.5.3. Ambulatory Surgical Centers
12.6. Market Size (US$ Mn) Forecast By Modality
12.6.1. Standalone
12.6.2. Portable
12.7. Market Attractiveness Analysis
12.7.1. By Country